Reaction
Inhalation Therapy reporting signals
As of the last recalculation, Inhalation Therapy appears in 630 FAERS reports alongside 7 co-occurring drug terms. The strongest observed disproportionality signal is FLUTICASONE PROPIONATE AND SALMETEROL (PRR 158.4).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Fluticasone Propionate And Salmeterol | 152 | 158.4 | 159.0 |
| Albuterol Sulfate | 360 | 92.2 | 92.3 |
| Fluticasone Propionate And Salmeterol Xinafoate | 123 | 83.8 | 84.0 |
| Salmeterol Xinafoate | 15 | 58.9 | 59.0 |
| Albuterol | 99 | 32.1 | 32.2 |
| Fluticasone Furoate And Vilanterol Trifenatate | 22 | 20.9 | 20.9 |
| Umeclidinium Bromide And Vilanterol Trifenatate | 10 | 20.1 | 20.1 |